Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure

Bernadet T. Santema; Michelle M. Y. Chan; Jasper Tromp; Martin Dokter; Haye H. van der Wal; Johanna E. Emmens; Janny Takens; Nilesh J. Samani; Leong L. Ng; Chim C. Lang; Peter van der Meer; Jozine M. Ter Maaten; Kevin Damman; Kenneth Dickstein; John G. Cleland; Faiez Zannad; Stefan D. Anker; Marco Metra; Pim van der Harst; Rudolf A. de Boer; Dirk J. van Veldhuisen; Michiel Rienstra; Carolyn S. P. Lam; Adriaan A. Voors

doi:10.1007/s00392-020-01762-2

Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure

Bernadet T. Santema, Michelle M. Y. Chan, Jasper Tromp, Martin Dokter, Haye H. van der Wal, Johanna E. Emmens, Janny Takens, Nilesh J. Samani, Leong L. Ng, Chim C. Lang, Peter van der Meer, Jozine M. Ter Maaten, Kevin Damman, Kenneth Dickstein, John G. Cleland, Faiez Zannad, Stefan D. Anker, Marco Metra, Pim van der Harst, Rudolf A. de BoerDirk J. van Veldhuisen, Michiel Rienstra, Carolyn S. P. Lam, Adriaan A. Voors (Lead / Corresponding author)

Molecular and Clinical Medicine

Research output: Contribution to journal › Article › peer-review

32 Downloads (Pure)

Abstract

The original version of this article unfortunately contained a mistake. Section “Results”, second paragraph, first sentence should read: The plasma levels of NT-proBNP were significantly higher in patients who had AF at baseline, with a median of 3417 pg/mL (1897–6486), as compared with patients who were in SR at baseline; both those who had a history of AF (1788 pg/mL [682–3870], p < 0.001) and those who never had AF before (2231 pg/mL [902–5270], p < 0.001) (Table 1), also after multivariable adjustment (Table 2).

Original language	English
Pages (from-to)	1351-1351
Number of pages	1
Journal	Clinical Research in Cardiology
Volume	110
Issue number	8
Early online date	3 Nov 2020
DOIs	https://doi.org/10.1007/s00392-020-01762-2
Publication status	Published - Aug 2021

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s00392-020-01762-2Licence: CC BY

Final Published VersionFinal published version, 475 KBLicence: CC BY

Cite this

Santema, B. T., Chan, M. M. Y., Tromp, J., Dokter, M., van der Wal, H. H., Emmens, J. E., Takens, J., Samani, N. J., Ng, L. L., Lang, C. C., van der Meer, P., Ter Maaten, J. M., Damman, K., Dickstein, K., Cleland, J. G., Zannad, F., Anker, S. D., Metra, M., van der Harst, P., ... Voors, A. A. (2021). Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure. Clinical Research in Cardiology , 110(8), 1351-1351. https://doi.org/10.1007/s00392-020-01762-2

@article{d63bf8afcfdc42a19acbfb8aa64f9599,

title = "Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure",

abstract = "The original version of this article unfortunately contained a mistake. Section “Results”, second paragraph, first sentence should read: The plasma levels of NT-proBNP were significantly higher in patients who had AF at baseline, with a median of 3417 pg/mL (1897–6486), as compared with patients who were in SR at baseline; both those who had a history of AF (1788 pg/mL [682–3870], p < 0.001) and those who never had AF before (2231 pg/mL [902–5270], p < 0.001) (Table 1), also after multivariable adjustment (Table 2).",

author = "Santema, {Bernadet T.} and Chan, {Michelle M. Y.} and Jasper Tromp and Martin Dokter and {van der Wal}, {Haye H.} and Emmens, {Johanna E.} and Janny Takens and Samani, {Nilesh J.} and Ng, {Leong L.} and Lang, {Chim C.} and {van der Meer}, Peter and {Ter Maaten}, {Jozine M.} and Kevin Damman and Kenneth Dickstein and Cleland, {John G.} and Faiez Zannad and Anker, {Stefan D.} and Marco Metra and {van der Harst}, Pim and {de Boer}, {Rudolf A.} and {van Veldhuisen}, {Dirk J.} and Michiel Rienstra and Lam, {Carolyn S. P.} and Voors, {Adriaan A.}",

year = "2021",

month = aug,

doi = "10.1007/s00392-020-01762-2",

language = "English",

volume = "110",

pages = "1351--1351",

journal = "Clinical Research in Cardiology ",

issn = "1861-0684",

publisher = "Springer ",

number = "8",

}

Santema, BT, Chan, MMY, Tromp, J, Dokter, M, van der Wal, HH, Emmens, JE, Takens, J, Samani, NJ, Ng, LL, Lang, CC, van der Meer, P, Ter Maaten, JM, Damman, K, Dickstein, K, Cleland, JG, Zannad, F, Anker, SD, Metra, M, van der Harst, P, de Boer, RA, van Veldhuisen, DJ, Rienstra, M, Lam, CSP & Voors, AA 2021, 'Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure', Clinical Research in Cardiology , vol. 110, no. 8, pp. 1351-1351. https://doi.org/10.1007/s00392-020-01762-2

TY - JOUR

T1 - Correction to

T2 - The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure

AU - Santema, Bernadet T.

AU - Chan, Michelle M. Y.

AU - Tromp, Jasper

AU - Dokter, Martin

AU - van der Wal, Haye H.

AU - Emmens, Johanna E.

AU - Takens, Janny

AU - Samani, Nilesh J.

AU - Ng, Leong L.

AU - Lang, Chim C.

AU - van der Meer, Peter

AU - Ter Maaten, Jozine M.

AU - Damman, Kevin

AU - Dickstein, Kenneth

AU - Cleland, John G.

AU - Zannad, Faiez

AU - Anker, Stefan D.

AU - Metra, Marco

AU - van der Harst, Pim

AU - de Boer, Rudolf A.

AU - van Veldhuisen, Dirk J.

AU - Rienstra, Michiel

AU - Lam, Carolyn S. P.

AU - Voors, Adriaan A.

PY - 2021/8

Y1 - 2021/8

N2 - The original version of this article unfortunately contained a mistake. Section “Results”, second paragraph, first sentence should read: The plasma levels of NT-proBNP were significantly higher in patients who had AF at baseline, with a median of 3417 pg/mL (1897–6486), as compared with patients who were in SR at baseline; both those who had a history of AF (1788 pg/mL [682–3870], p < 0.001) and those who never had AF before (2231 pg/mL [902–5270], p < 0.001) (Table 1), also after multivariable adjustment (Table 2).

AB - The original version of this article unfortunately contained a mistake. Section “Results”, second paragraph, first sentence should read: The plasma levels of NT-proBNP were significantly higher in patients who had AF at baseline, with a median of 3417 pg/mL (1897–6486), as compared with patients who were in SR at baseline; both those who had a history of AF (1788 pg/mL [682–3870], p < 0.001) and those who never had AF before (2231 pg/mL [902–5270], p < 0.001) (Table 1), also after multivariable adjustment (Table 2).

UR - http://www.scopus.com/inward/record.url?scp=85094911747&partnerID=8YFLogxK

U2 - 10.1007/s00392-020-01762-2

DO - 10.1007/s00392-020-01762-2

M3 - Article

C2 - 33141252

SN - 1861-0684

VL - 110

SP - 1351

EP - 1351

JO - Clinical Research in Cardiology

JF - Clinical Research in Cardiology

IS - 8

ER -

Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this